Federal Register Recent Federal Regulation Documents - Justia Regulation Tracker - Justia Regulations Trackerhttps://regulations.justia.com/regulations/fedreg/agencies/department-of-health-and-human-services/2023/03/07?limit=200®isters=between&mode=atom2025-03-04T04:00:32-08:00Justia Inchttps://www.justia.com/Justia Regulations Trackerhttps://regulations.justia.com/images/justiafedregulations.gifCopyright 2011 Justia Inchttps://regulations.justia.com/regulations/fedreg/2023/03/07/2023-04564.htmlNotice - Fosun Pharma USA Inc.; Withdrawal of Approval of Abbreviated New Drug Application for Pemoline Tablets, 18.75 Milligrams, 37.5 Milligrams, and 75 Milligrams2023-03-07T00:00:00-08:002023-03-07T00:00:00-08:002023-04564Noticehttps://www.govinfo.gov/content/pkg/FR-2023-03-07/pdf/2023-04564.pdfhttps://regulations.justia.com/regulations/fedreg/2023/03/07/2023-04562.htmlNotice - Evaluating the Safety of Antimicrobial New Animal Drugs With Regard to Their Microbiological Effects on Bacteria of Human Health Concern; Revised Draft Guidance for Industry; Availability; Extension of Comment Period2023-03-07T00:00:00-08:002023-03-07T00:00:00-08:002023-04562Noticehttps://www.govinfo.gov/content/pkg/FR-2023-03-07/pdf/2023-04562.pdfhttps://regulations.justia.com/regulations/fedreg/2023/03/07/2023-04628.htmlNotice - Submission for OMB Review; 30-Day Comment Request; NCI Genomic Data Commons (GDC) Data Submission Request Form (National Cancer Institute)2023-03-07T00:00:00-08:002023-03-07T00:00:00-08:002023-04628Noticehttps://www.govinfo.gov/content/pkg/FR-2023-03-07/pdf/2023-04628.pdfhttps://regulations.justia.com/regulations/fedreg/2023/03/07/2023-04585.htmlNotice - Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Rural Health Network Development Planning Program2023-03-07T00:00:00-08:002023-03-07T00:00:00-08:002023-04585Noticehttps://www.govinfo.gov/content/pkg/FR-2023-03-07/pdf/2023-04585.pdfhttps://regulations.justia.com/regulations/fedreg/2023/03/07/2023-04583.htmlNotice - Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar or Interchangeable Biosimilar Applicant2023-03-07T00:00:00-08:002023-03-07T00:00:00-08:002023-04583Noticehttps://www.govinfo.gov/content/pkg/FR-2023-03-07/pdf/2023-04583.pdfhttps://regulations.justia.com/regulations/fedreg/2023/03/07/2023-04622.htmlNotice - Center for Scientific Review; Notice of Meeting2023-03-07T00:00:00-08:002023-03-07T00:00:00-08:002023-04622Noticehttps://www.govinfo.gov/content/pkg/FR-2023-03-07/pdf/2023-04622.pdfhttps://regulations.justia.com/regulations/fedreg/2023/03/07/2023-04621.htmlNotice - National Institute on Aging; Notice of Closed Meeting2023-03-07T00:00:00-08:002023-03-07T00:00:00-08:002023-04621Noticehttps://www.govinfo.gov/content/pkg/FR-2023-03-07/pdf/2023-04621.pdfhttps://regulations.justia.com/regulations/fedreg/2023/03/07/2023-04561.htmlNotice - Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting2023-03-07T00:00:00-08:002023-03-07T00:00:00-08:002023-04561Noticehttps://www.govinfo.gov/content/pkg/FR-2023-03-07/pdf/2023-04561.pdfhttps://regulations.justia.com/regulations/fedreg/2023/03/07/2023-04560.htmlNotice - Determination That Lithium Citrate Oral Solution, 8 Milliequivalents/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness2023-03-07T00:00:00-08:002023-03-07T00:00:00-08:002023-04560Noticehttps://www.govinfo.gov/content/pkg/FR-2023-03-07/pdf/2023-04560.pdf